Sorrento Therapeutics Inc (SRNE)

[cheynew]

Not so very soon.

“ The study is expected to enroll 60 patients (in 4 dosing regimen cohorts) in about six months from the date of first enrollment. The primary outcome measure will be improvement in the 6-Minute Walk Distance (6MWD) test at Day 60 post-treatment.”